0 followers
Journey Colab is pursuing FDA approval of psychedelic therapies to heal individual mental health and strengthen communities. They plan to build a portfolio of plant-identical compounds. Their first compound in development is mescaline.
Bristol-Myers Squibb
205 followers
Prescient Healthcare Group
26 followers
NYU Langone Health
14 followers
PCI Pharma Services
7 followers
Cytel
5 followers
Agios Pharmaceuticals
5 followers
AbbVie
196 followers
Cambrex
3 followers
PPD
19 followers
Corcept Therapeutics
2 followers
Intra-Cellular Therapies
1 follower
Explore companies